AZURECELL
Live / Allowed — Published for opposition (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79448144
- Mark type
- Stylized text
- Filed
- 14 Jan 2026
- Published for opposition
- 08 Sept 2026
- Attorney of record
- Andrea L. Hintz
Goods and services
- Class 001 — Chemicals: Biological preparations for use in cell cultures, other than for medical or veterinary use; stem cells other than for medical or veterinary use; cells other than for medical or veterinary use; cell culture reagents for scientific and research use; biological preparations, namely, fluid matrices for use in scientific and medical research; cell culture media other than for medical or veterinary use; biological preparations, namely, cell lines for scientific use; molecular genetics reagents, plasmids being small independently replicating pieces of DNA, and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for scientific use
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of neurodegenerative disorders; diagnostic preparations for medical and veterinary use; pharmaceutical preparations for activating cellular functions; medical preparations for the treatment of the brain and nervous system, namely, neurodegenerative diseases and movement disorders; medical preparations for the treatment of Parkinson's disease; biotechnological preparations for medical use, namely, stem cell-derived cellular preparations for the treatment of neurological disorders and genetically engineered cellular preparations for the treatment of neurological disorders; biotechnological preparations for medical use, namely, gene or cell therapy; cells for medical use; living cells and living biological tissue cultures for medical use; theranostic therapeutic cells for medical purposes; surgical implants comprised of living tissues and cells; chemical or biological reagents and cell culture media for medical use; diagnostic agents for medical use; diagnostic kits comprising diagnostic agents, preparations and substances for medical use
- Class 044 — Medical, beauty and agricultural services: Medical services; regenerative medicine services; cultured cell bank services for medical transplantation; medical treatment services by means of cultured cells; medical treatment services by means of stem cell therapy; providing regenerative medicine services for third parties in the form of cell culture services, namely, preparation, expansion and characterization of cells to be used for therapeutic purposes; providing clinical advice on cell therapy; genetic analysis services for medical use
Owner
- AZURECELL SA, CH
- AZURECELL SA, CH
Prosecution history
- 08 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Sept 2026 — PUBLISHED FOR OPPOSITION
- 03 Sept 2026 — NOTIFICATION PROCESSED BY IB
- 02 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 19 Aug 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 10 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 30 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Jul 2026 — REFUSAL PROCESSED BY IB